REQUEST A DEMO
Total
USD $0.00
Search more companies

Narodowy Instytut Lekow (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Secondary Activities: Periodical Publishers | Book Publishers | Other Publishers | Scientific Research and Development Services | Research and Development in Biotechnology (except Nanobiotechnology) | All Other Miscellaneous Schools and Instruction | All Other Miscellaneous Ambulatory Health Care Services
Full name: Narodowy Instytut Lekow Profile Updated: February 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English & Polish Download a sample report

Narodowy Instytut Lekow is an enterprise in Poland, with the main office in Warsaw. The company operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. It was incorporated on November 27, 2002. 250 (2005) employees currently work for Narodowy Instytut Lekow. From the latest financial highlights, Narodowy Instytut Lekow reported a net sales revenue drop of 5.57% in 2021. Its’ total assets recorded a growth of 2.84%. The net profit margin of Narodowy Instytut Lekow decreased by 3.62% in 2021.

Headquarters
Ul. Chelmska 30/34
Warsaw; Mazowieckie; Postal Code: 00-725

Contact Details: Purchase the Narodowy Instytut Lekow report to view the information.

Website: http://www.nil.gov.pl

Basic Information
Total Employees:
Purchase the Narodowy Instytut Lekow report to view the information.
Outstanding Shares:
Purchase the Narodowy Instytut Lekow report to view the information.
Financial Auditors:
Purchase the Narodowy Instytut Lekow report to view the information.
Incorporation Date:
November 27, 2002
Key Executives
Purchase this report to view the information.
Proxy
Purchase this report to view the information.
Dyrektor Narodowego Instytutu Lekow
Subsidiaries
Innonil Sp. z o.o.
100%
Company Performance
Financial values in the chart are available after Narodowy Instytut Lekow report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-5.57%
Total operating revenue
-4.98%
Operating profit (EBIT)
-76.94%
EBITDA
-39.97%
Net Profit (Loss) for the Period
-79.81%
Total assets
2.84%
Total equity
6.12%
Operating Profit Margin (ROS)
-3.49%
Net Profit Margin
-3.62%
Return on Equity (ROE)
-27.83%
Quick Ratio
0.11%
Cash Ratio
0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?